Industry Research Reports

Home > Reports > Machinery & Equipment > Global Everolimus Market Insights, Forecast to 2030

Global Everolimus Market Insights, Forecast to 2030

Industry: Machinery & Equipment

Published Date: 2024-04-25

Pages: 70 Pages

Report ld: 3054158

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Everolimus Market Size(US$)

CAGR 2024-2030

-7.6%

Market Size,2030

USD 255.2

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 410 million

Market Forecast in 2030(Value)

US$ 255.2 million

CAGR

-7.6%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Afinitor (everolimus) is a brand-name prescription medication. It's used to treat certain types of cancers, tumors, and seizures.

The global Everolimus market is projected to grow from US$ 410 million in 2024 to US$ 255.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of -7.6% during the forecast period.

Everolimus, a targeted therapy used in the treatment of various cancers, is witnessing increasing demand. Factors contributing to market growth include the rising prevalence of cancer, advancements in precision medicine, and the expanding pipeline of Afinitor for new indications. Key players in the market are investing in research and development to expand the application of Afinitor and develop combination therapies. Additionally, strategic collaborations and partnerships are driving market expansion. However, challenges such as high treatment costs and the availability of alternative therapies may hinder market growth.

In terms of production side, this report researches the Everolimus production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Everolimus by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

Report Covers:

This report presents an overview of global market for Everolimus, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Everolimus, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Everolimus, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Everolimus sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Everolimus market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Everolimus sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Novartis. etc.

MARKET SEGMENTATION

By Company

Novartis

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

2.5mg
5mg
7mg
10mg

Segment by Application

Hospital
Drugs Store
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Everolimus production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of Everolimus in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Everolimus manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: China by Type, and by Application, sales, and revenue for each segment.

Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Everolimus sales, revenue, price, gross margin, and recent development, etc.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 15: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Everolimus Product Introduction

1.2 Market by Type

1.2.1 Global Everolimus Market Size by Type, 2019 VS 2023 VS 2030

1.2.2 2.5mg

1.2.3 5mg

1.2.4 7mg

1.2.5 10mg

1.3 Market by Application

1.3.1 Global Everolimus Market Size by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Drugs Store

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Everolimus Production

2.1 Global Everolimus Production Capacity (2019-2030)

2.2 Global Everolimus Production by Region: 2019 VS 2023 VS 2030

2.3 Global Everolimus Production by Region

2.3.1 Global Everolimus Historic Production by Region (2019-2024)

2.3.2 Global Everolimus Forecasted Production by Region (2025-2030)

2.3.3 Global Everolimus Production Market Share by Region (2019-2030)

2.4 North America

3 Executive Summary

3.1 Global Everolimus Revenue Estimates and Forecasts 2019-2030

3.2 Global Everolimus Revenue by Region

3.2.1 Global Everolimus Revenue by Region: 2019 VS 2023 VS 2030

3.2.2 Global Everolimus Revenue by Region (2019-2024)

3.2.3 Global Everolimus Revenue by Region (2025-2030)

3.2.4 Global Everolimus Revenue Market Share by Region (2019-2030)

3.3 Global Everolimus Sales Estimates and Forecasts 2019-2030

3.4 Global Everolimus Sales by Region

3.4.1 Global Everolimus Sales by Region: 2019 VS 2023 VS 2030

3.4.2 Global Everolimus Sales by Region (2019-2024)

3.4.3 Global Everolimus Sales by Region (2025-2030)

3.4.4 Global Everolimus Sales Market Share by Region (2019-2030)

3.5 US & Canada

3.6 Europe

3.7 China

3.8 Asia (excluding China)

3.9 Middle East, Africa and Latin America

4 Competition by Manufactures

4.1 Global Everolimus Sales by Manufacturers

4.1.1 Global Everolimus Sales by Manufacturers (2019-2024)

4.1.2 Global Everolimus Sales Market Share by Manufacturers (2019-2024)

4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Everolimus in 2023

4.2 Global Everolimus Revenue by Manufacturers

4.2.1 Global Everolimus Revenue by Manufacturers (2019-2024)

4.2.2 Global Everolimus Revenue Market Share by Manufacturers (2019-2024)

4.2.3 Global Top 10 and Top 5 Companies by Everolimus Revenue in 2023

4.3 Global Everolimus Sales Price by Manufacturers

4.4 Global Key Players of Everolimus, Industry Ranking, 2022 VS 2023 VS 2024

4.5 Analysis of Competitive Landscape

4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

4.5.2 Global Everolimus Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.6 Global Key Manufacturers of Everolimus, Manufacturing Base Distribution and Headquarters

4.7 Global Key Manufacturers of Everolimus, Product Offered and Application

4.8 Global Key Manufacturers of Everolimus, Date of Enter into This Industry

4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

5.1 Global Everolimus Sales by Type

5.1.1 Global Everolimus Historical Sales by Type (2019-2024)

5.1.2 Global Everolimus Forecasted Sales by Type (2025-2030)

5.1.3 Global Everolimus Sales Market Share by Type (2019-2030)

5.2 Global Everolimus Revenue by Type

5.2.1 Global Everolimus Historical Revenue by Type (2019-2024)

5.2.2 Global Everolimus Forecasted Revenue by Type (2025-2030)

5.2.3 Global Everolimus Revenue Market Share by Type (2019-2030)

5.3 Global Everolimus Price by Type

5.3.1 Global Everolimus Price by Type (2019-2024)

5.3.2 Global Everolimus Price Forecast by Type (2025-2030)

6 Market Size by Application

6.1 Global Everolimus Sales by Application

6.1.1 Global Everolimus Historical Sales by Application (2019-2024)

6.1.2 Global Everolimus Forecasted Sales by Application (2025-2030)

6.1.3 Global Everolimus Sales Market Share by Application (2019-2030)

6.2 Global Everolimus Revenue by Application

6.2.1 Global Everolimus Historical Revenue by Application (2019-2024)

6.2.2 Global Everolimus Forecasted Revenue by Application (2025-2030)

6.2.3 Global Everolimus Revenue Market Share by Application (2019-2030)

6.3 Global Everolimus Price by Application

6.3.1 Global Everolimus Price by Application (2019-2024)

6.3.2 Global Everolimus Price Forecast by Application (2025-2030)

7 US & Canada

7.1 US & Canada Everolimus Market Size by Type

7.1.1 US & Canada Everolimus Sales by Type (2019-2030)

7.1.2 US & Canada Everolimus Revenue by Type (2019-2030)

7.2 US & Canada Everolimus Market Size by Application

7.2.1 US & Canada Everolimus Sales by Application (2019-2030)

7.2.2 US & Canada Everolimus Revenue by Application (2019-2030)

7.3 US & Canada Everolimus Sales by Country

7.3.1 US & Canada Everolimus Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 US & Canada Everolimus Sales by Country (2019-2030)

7.3.3 US & Canada Everolimus Revenue by Country (2019-2030)

7.3.4 the United States

7.3.5 Canada

8 Europe

8.1 Europe Everolimus Market Size by Type

8.1.1 Europe Everolimus Sales by Type (2019-2030)

8.1.2 Europe Everolimus Revenue by Type (2019-2030)

8.2 Europe Everolimus Market Size by Application

8.2.1 Europe Everolimus Sales by Application (2019-2030)

8.2.2 Europe Everolimus Revenue by Application (2019-2030)

8.3 Europe Everolimus Sales by Country

8.3.1 Europe Everolimus Revenue by Country: 2019 VS 2023 VS 2030

8.3.2 Europe Everolimus Sales by Country (2019-2030)

8.3.3 Europe Everolimus Revenue by Country (2019-2030)

8.3.4 Germany

8.3.5 France

8.3.6 UK

8.3.7 Italy

8.3.8 Russia

9 China

9.1 China Everolimus Market Size by Type

9.1.1 China Everolimus Sales by Type (2019-2030)

9.1.2 China Everolimus Revenue by Type (2019-2030)

9.2 China Everolimus Market Size by Application

9.2.1 China Everolimus Sales by Application (2019-2030)

9.2.2 China Everolimus Revenue by Application (2019-2030)

10 Asia (excluding China)

10.1 Asia Everolimus Market Size by Type

10.1.1 Asia Everolimus Sales by Type (2019-2030)

10.1.2 Asia Everolimus Revenue by Type (2019-2030)

10.2 Asia Everolimus Market Size by Application

10.2.1 Asia Everolimus Sales by Application (2019-2030)

10.2.2 Asia Everolimus Revenue by Application (2019-2030)

10.3 Asia Everolimus Sales by Region

10.3.1 Asia Everolimus Revenue by Region: 2019 VS 2023 VS 2030

10.3.2 Asia Everolimus Revenue by Region (2019-2030)

10.3.3 Asia Everolimus Sales by Region (2019-2030)

10.3.4 Japan

10.3.5 South Korea

10.3.6 China Taiwan

10.3.7 Southeast Asia

10.3.8 India

11 Middle East, Africa and Latin America

11.1 Middle East, Africa and Latin America Everolimus Market Size by Type

11.1.1 Middle East, Africa and Latin America Everolimus Sales by Type (2019-2030)

11.1.2 Middle East, Africa and Latin America Everolimus Revenue by Type (2019-2030)

11.2 Middle East, Africa and Latin America Everolimus Market Size by Application

11.2.1 Middle East, Africa and Latin America Everolimus Sales by Application (2019-2030)

11.2.2 Middle East, Africa and Latin America Everolimus Revenue by Application (2019-2030)

11.3 Middle East, Africa and Latin America Everolimus Sales by Country

11.3.1 Middle East, Africa and Latin America Everolimus Revenue by Country: 2019 VS 2023 VS 2030

11.3.2 Middle East, Africa and Latin America Everolimus Revenue by Country (2019-2030)

11.3.3 Middle East, Africa and Latin America Everolimus Sales by Country (2019-2030)

11.3.4 Brazil

11.3.5 Mexico

11.3.6 Turkey

11.3.7 Israel

11.3.8 GCC Countries

12 Corporate Profiles

12.1 Novartis

12.1.1 Novartis Company Information

12.1.2 Novartis Overview

12.1.3 Novartis Everolimus Sales, Price, Revenue and Gross Margin (2019-2024)

12.1.4 Novartis Everolimus Product Model Numbers, Pictures, Descriptions and Specifications

12.1.5 Novartis Recent Developments

13 Industry Chain and Sales Channels Analysis

13.1 Everolimus Industry Chain Analysis

13.2 Everolimus Key Raw Materials

13.2.1 Key Raw Materials

13.2.2 Raw Materials Key Suppliers

13.3 Everolimus Production Mode & Process

13.4 Everolimus Sales and Marketing

13.4.1 Everolimus Sales Channels

13.4.2 Everolimus Distributors

13.5 Everolimus Customers

14 Everolimus Market Dynamics

14.1 Everolimus Industry Trends

14.2 Everolimus Market Drivers

14.3 Everolimus Market Challenges

14.4 Everolimus Market Restraints

15 Key Finding in The Global Everolimus Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Everolimus Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of 2.5mg

Table 3. Major Manufacturers of 5mg

Table 4. Major Manufacturers of 7mg

Table 5. Major Manufacturers of 10mg

Table 6. Global Everolimus Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Everolimus Production by Region: 2019 VS 2023 VS 2030 (K Units)

Table 8. Global Everolimus Production by Region (2019-2024) & (K Units)

Table 9. Global Everolimus Production by Region (2025-2030) & (K Units)

Table 10. Global Everolimus Production Market Share by Region (2019-2024)

Table 11. Global Everolimus Production Market Share by Region (2025-2030)

Table 12. Global Everolimus Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 13. Global Everolimus Revenue by Region (2019-2024) & (US$ Million)

Table 14. Global Everolimus Revenue by Region (2025-2030) & (US$ Million)

Table 15. Global Everolimus Revenue Market Share by Region (2019-2024)

Table 16. Global Everolimus Revenue Market Share by Region (2025-2030)

Table 17. Global Everolimus Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 18. Global Everolimus Sales by Region (2019-2024) & (K Units)

Table 19. Global Everolimus Sales by Region (2025-2030) & (K Units)

Table 20. Global Everolimus Sales Market Share by Region (2019-2024)

Table 21. Global Everolimus Sales Market Share by Region (2025-2030)

Table 22. Global Everolimus Sales by Manufacturers (2019-2024) & (K Units)

Table 23. Global Everolimus Sales Share by Manufacturers (2019-2024)

Table 24. Global Everolimus Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 25. Global Everolimus Revenue Share by Manufacturers (2019-2024)

Table 26. Everolimus Price by Manufacturers 2019-2024 (USD/Unit)

Table 27. Global Key Players of Everolimus, Industry Ranking, 2022 VS 2023 VS 2024

Table 28. Global Everolimus Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 29. Global Everolimus by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Everolimus as of 2023)

Table 30. Global Key Manufacturers of Everolimus, Manufacturing Base Distribution and Headquarters

Table 31. Global Key Manufacturers of Everolimus, Product Offered and Application

Table 32. Global Key Manufacturers of Everolimus, Date of Enter into This Industry

Table 33. Mergers & Acquisitions, Expansion Plans

Table 34. Global Everolimus Sales by Type (2019-2024) & (K Units)

Table 35. Global Everolimus Sales by Type (2025-2030) & (K Units)

Table 36. Global Everolimus Sales Share by Type (2019-2024)

Table 37. Global Everolimus Sales Share by Type (2025-2030)

Table 38. Global Everolimus Revenue by Type (2019-2024) & (US$ Million)

Table 39. Global Everolimus Revenue by Type (2025-2030) & (US$ Million)

Table 40. Global Everolimus Revenue Share by Type (2019-2024)

Table 41. Global Everolimus Revenue Share by Type (2025-2030)

Table 42. Everolimus Price by Type (2019-2024) & (USD/Unit)

Table 43. Global Everolimus Price Forecast by Type (2025-2030) & (USD/Unit)

Table 44. Global Everolimus Sales by Application (2019-2024) & (K Units)

Table 45. Global Everolimus Sales by Application (2025-2030) & (K Units)

Table 46. Global Everolimus Sales Share by Application (2019-2024)

Table 47. Global Everolimus Sales Share by Application (2025-2030)

Table 48. Global Everolimus Revenue by Application (2019-2024) & (US$ Million)

Table 49. Global Everolimus Revenue by Application (2025-2030) & (US$ Million)

Table 50. Global Everolimus Revenue Share by Application (2019-2024)

Table 51. Global Everolimus Revenue Share by Application (2025-2030)

Table 52. Everolimus Price by Application (2019-2024) & (USD/Unit)

Table 53. Global Everolimus Price Forecast by Application (2025-2030) & (USD/Unit)

Table 54. US & Canada Everolimus Sales by Type (2019-2024) & (K Units)

Table 55. US & Canada Everolimus Sales by Type (2025-2030) & (K Units)

Table 56. US & Canada Everolimus Revenue by Type (2019-2024) & (US$ Million)

Table 57. US & Canada Everolimus Revenue by Type (2025-2030) & (US$ Million)

Table 58. US & Canada Everolimus Sales by Application (2019-2024) & (K Units)

Table 59. US & Canada Everolimus Sales by Application (2025-2030) & (K Units)

Table 60. US & Canada Everolimus Revenue by Application (2019-2024) & (US$ Million)

Table 61. US & Canada Everolimus Revenue by Application (2025-2030) & (US$ Million)

Table 62. US & Canada Everolimus Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 63. US & Canada Everolimus Revenue by Country (2019-2024) & (US$ Million)

Table 64. US & Canada Everolimus Revenue by Country (2025-2030) & (US$ Million)

Table 65. US & Canada Everolimus Sales by Country (2019-2024) & (K Units)

Table 66. US & Canada Everolimus Sales by Country (2025-2030) & (K Units)

Table 67. Europe Everolimus Sales by Type (2019-2024) & (K Units)

Table 68. Europe Everolimus Sales by Type (2025-2030) & (K Units)

Table 69. Europe Everolimus Revenue by Type (2019-2024) & (US$ Million)

Table 70. Europe Everolimus Revenue by Type (2025-2030) & (US$ Million)

Table 71. Europe Everolimus Sales by Application (2019-2024) & (K Units)

Table 72. Europe Everolimus Sales by Application (2025-2030) & (K Units)

Table 73. Europe Everolimus Revenue by Application (2019-2024) & (US$ Million)

Table 74. Europe Everolimus Revenue by Application (2025-2030) & (US$ Million)

Table 75. Europe Everolimus Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 76. Europe Everolimus Revenue by Country (2019-2024) & (US$ Million)

Table 77. Europe Everolimus Revenue by Country (2025-2030) & (US$ Million)

Table 78. Europe Everolimus Sales by Country (2019-2024) & (K Units)

Table 79. Europe Everolimus Sales by Country (2025-2030) & (K Units)

Table 80. China Everolimus Sales by Type (2019-2024) & (K Units)

Table 81. China Everolimus Sales by Type (2025-2030) & (K Units)

Table 82. China Everolimus Revenue by Type (2019-2024) & (US$ Million)

Table 83. China Everolimus Revenue by Type (2025-2030) & (US$ Million)

Table 84. China Everolimus Sales by Application (2019-2024) & (K Units)

Table 85. China Everolimus Sales by Application (2025-2030) & (K Units)

Table 86. China Everolimus Revenue by Application (2019-2024) & (US$ Million)

Table 87. China Everolimus Revenue by Application (2025-2030) & (US$ Million)

Table 88. Asia Everolimus Sales by Type (2019-2024) & (K Units)

Table 89. Asia Everolimus Sales by Type (2025-2030) & (K Units)

Table 90. Asia Everolimus Revenue by Type (2019-2024) & (US$ Million)

Table 91. Asia Everolimus Revenue by Type (2025-2030) & (US$ Million)

Table 92. Asia Everolimus Sales by Application (2019-2024) & (K Units)

Table 93. Asia Everolimus Sales by Application (2025-2030) & (K Units)

Table 94. Asia Everolimus Revenue by Application (2019-2024) & (US$ Million)

Table 95. Asia Everolimus Revenue by Application (2025-2030) & (US$ Million)

Table 96. Asia Everolimus Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 97. Asia Everolimus Revenue by Region (2019-2024) & (US$ Million)

Table 98. Asia Everolimus Revenue by Region (2025-2030) & (US$ Million)

Table 99. Asia Everolimus Sales by Region (2019-2024) & (K Units)

Table 100. Asia Everolimus Sales by Region (2025-2030) & (K Units)

Table 101. Middle East, Africa and Latin America Everolimus Sales by Type (2019-2024) & (K Units)

Table 102. Middle East, Africa and Latin America Everolimus Sales by Type (2025-2030) & (K Units)

Table 103. Middle East, Africa and Latin America Everolimus Revenue by Type (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Everolimus Revenue by Type (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Everolimus Sales by Application (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Everolimus Sales by Application (2025-2030) & (K Units)

Table 107. Middle East, Africa and Latin America Everolimus Revenue by Application (2019-2024) & (US$ Million)

Table 108. Middle East, Africa and Latin America Everolimus Revenue by Application (2025-2030) & (US$ Million)

Table 109. Middle East, Africa and Latin America Everolimus Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 110. Middle East, Africa and Latin America Everolimus Revenue by Country (2019-2024) & (US$ Million)

Table 111. Middle East, Africa and Latin America Everolimus Revenue by Country (2025-2030) & (US$ Million)

Table 112. Middle East, Africa and Latin America Everolimus Sales by Country (2019-2024) & (K Units)

Table 113. Middle East, Africa and Latin America Everolimus Sales by Country (2025-2030) & (K Units)

Table 114. Novartis Company Information

Table 115. Novartis Description and Major Businesses

Table 116. Novartis Everolimus Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 117. Novartis Everolimus Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Novartis Recent Development

Table 119. Key Raw Materials Lists

Table 120. Raw Materials Key Suppliers Lists

Table 121. Everolimus Distributors List

Table 122. Everolimus Customers List

Table 123. Everolimus Market Trends

Table 124. Everolimus Market Drivers

Table 125. Everolimus Market Challenges

Table 126. Everolimus Market Restraints

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

List of Figures

Figure 1. Everolimus Product Picture

Figure 2. Global Everolimus Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Everolimus Market Share by Type in 2023 & 2030

Figure 4. 2.5mg Product Picture

Figure 5. 5mg Product Picture

Figure 6. 7mg Product Picture

Figure 7. 10mg Product Picture

Figure 8. Global Everolimus Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Everolimus Market Share by Application in 2023 & 2030

Figure 10. Hospital

Figure 11. Drugs Store

Figure 12. Other

Figure 13. Everolimus Report Years Considered

Figure 14. Global Everolimus Capacity, Production and Utilization (2019-2030) & (K Units)

Figure 15. Global Everolimus Production Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Everolimus Production Market Share by Region (2019-2030)

Figure 17. Everolimus Production Growth Rate in North America (2019-2030) & (K Units)

Figure 18. Global Everolimus Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Everolimus Revenue 2019-2030 (US$ Million)

Figure 20. Global Everolimus Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 21. Global Everolimus Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 22. Global Everolimus Revenue Market Share by Region (2019-2030)

Figure 23. Global Everolimus Sales 2019-2030 ((K Units)

Figure 24. Global Everolimus Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 25. Global Everolimus Sales Market Share by Region (2019-2030)

Figure 26. US & Canada Everolimus Sales YoY (2019-2030) & (K Units)

Figure 27. US & Canada Everolimus Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Europe Everolimus Sales YoY (2019-2030) & (K Units)

Figure 29. Europe Everolimus Revenue YoY (2019-2030) & (US$ Million)

Figure 30. China Everolimus Sales YoY (2019-2030) & (K Units)

Figure 31. China Everolimus Revenue YoY (2019-2030) & (US$ Million)

Figure 32. Asia (excluding China) Everolimus Sales YoY (2019-2030) & (K Units)

Figure 33. Asia (excluding China) Everolimus Revenue YoY (2019-2030) & (US$ Million)

Figure 34. Middle East, Africa and Latin America Everolimus Sales YoY (2019-2030) & (K Units)

Figure 35. Middle East, Africa and Latin America Everolimus Revenue YoY (2019-2030) & (US$ Million)

Figure 36. The Everolimus Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 37. The Top 5 and 10 Largest Manufacturers of Everolimus in the World: Market Share by Everolimus Revenue in 2023

Figure 38. Global Everolimus Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 39. Global Everolimus Sales Market Share by Type (2019-2030)

Figure 40. Global Everolimus Revenue Market Share by Type (2019-2030)

Figure 41. Global Everolimus Sales Market Share by Application (2019-2030)

Figure 42. Global Everolimus Revenue Market Share by Application (2019-2030)

Figure 43. US & Canada Everolimus Sales Market Share by Type (2019-2030)

Figure 44. US & Canada Everolimus Revenue Market Share by Type (2019-2030)

Figure 45. US & Canada Everolimus Sales Market Share by Application (2019-2030)

Figure 46. US & Canada Everolimus Revenue Market Share by Application (2019-2030)

Figure 47. US & Canada Everolimus Revenue Share by Country (2019-2030)

Figure 48. US & Canada Everolimus Sales Share by Country (2019-2030)

Figure 49. U.S. Everolimus Revenue (2019-2030) & (US$ Million)

Figure 50. Canada Everolimus Revenue (2019-2030) & (US$ Million)

Figure 51. Europe Everolimus Sales Market Share by Type (2019-2030)

Figure 52. Europe Everolimus Revenue Market Share by Type (2019-2030)

Figure 53. Europe Everolimus Sales Market Share by Application (2019-2030)

Figure 54. Europe Everolimus Revenue Market Share by Application (2019-2030)

Figure 55. Europe Everolimus Revenue Share by Country (2019-2030)

Figure 56. Europe Everolimus Sales Share by Country (2019-2030)

Figure 57. Germany Everolimus Revenue (2019-2030) & (US$ Million)

Figure 58. France Everolimus Revenue (2019-2030) & (US$ Million)

Figure 59. UK Everolimus Revenue (2019-2030) & (US$ Million)

Figure 60. Italy Everolimus Revenue (2019-2030) & (US$ Million)

Figure 61. Russia Everolimus Revenue (2019-2030) & (US$ Million)

Figure 62. China Everolimus Sales Market Share by Type (2019-2030)

Figure 63. China Everolimus Revenue Market Share by Type (2019-2030)

Figure 64. China Everolimus Sales Market Share by Application (2019-2030)

Figure 65. China Everolimus Revenue Market Share by Application (2019-2030)

Figure 66. Asia Everolimus Sales Market Share by Type (2019-2030)

Figure 67. Asia Everolimus Revenue Market Share by Type (2019-2030)

Figure 68. Asia Everolimus Sales Market Share by Application (2019-2030)

Figure 69. Asia Everolimus Revenue Market Share by Application (2019-2030)

Figure 70. Asia Everolimus Revenue Share by Region (2019-2030)

Figure 71. Asia Everolimus Sales Share by Region (2019-2030)

Figure 72. Japan Everolimus Revenue (2019-2030) & (US$ Million)

Figure 73. South Korea Everolimus Revenue (2019-2030) & (US$ Million)

Figure 74. China Taiwan Everolimus Revenue (2019-2030) & (US$ Million)

Figure 75. Southeast Asia Everolimus Revenue (2019-2030) & (US$ Million)

Figure 76. India Everolimus Revenue (2019-2030) & (US$ Million)

Figure 77. Middle East, Africa and Latin America Everolimus Sales Market Share by Type (2019-2030)

Figure 78. Middle East, Africa and Latin America Everolimus Revenue Market Share by Type (2019-2030)

Figure 79. Middle East, Africa and Latin America Everolimus Sales Market Share by Application (2019-2030)

Figure 80. Middle East, Africa and Latin America Everolimus Revenue Market Share by Application (2019-2030)

Figure 81. Middle East, Africa and Latin America Everolimus Revenue Share by Country (2019-2030)

Figure 82. Middle East, Africa and Latin America Everolimus Sales Share by Country (2019-2030)

Figure 83. Brazil Everolimus Revenue (2019-2030) & (US$ Million)

Figure 84. Mexico Everolimus Revenue (2019-2030) & (US$ Million)

Figure 85. Turkey Everolimus Revenue (2019-2030) & (US$ Million)

Figure 86. Israel Everolimus Revenue (2019-2030) & (US$ Million)

Figure 87. GCC Countries Everolimus Revenue (2019-2030) & (US$ Million)

Figure 88. Everolimus Value Chain

Figure 89. Everolimus Production Process

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Bottom-up and Top-down Approaches for This Report

Figure 93. Data Triangulation

Figure 94. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Everolimus in 2024? zhanKai

The global market size of Everolimus in 2024 was 410 Million USD.

Which region is expected to have the highest market share? shouQi

What was the global market size of Everolimus in 2030? shouQi

What is the annual compound growth rate of the global Everolimus market size from 2024 to 2030? shouQi

Which companies rank high in the global Everolimus market? shouQi

Related Reports

Everolimus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Everolimus was estimated to be worth US$ 356 million in 2025 and is projected to reach US$ 206 million, growing at a CAGR of -7.6% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 116
USD 3950.00
(Single User License)
Global Everolimus Market Research Report 2026
The global Everolimus market was valued at US$ 356 million in 2025 and is anticipated to reach US$ 206 million by 2032, at a CAGR of -7.6% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 123
USD 2900.00
(Single User License)
Global Everolimus Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Everolimus market is projected to grow from US$ 382 million in 2024 to US$ 221 million by 2031, at a CAGR of -7.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-30
Pages: 110
USD 4900.00
(Single User License)
Global Everolimus Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Everolimus market size was US$ 382 million in 2024 and is forecast to a readjusted size of US$ 221 million by 2031 with a CAGR of -7.6% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 73
USD 4250.00
(Single User License)
Everolimus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Everolimus was estimated to be worth US$ 382 million in 2024 and is forecast to a readjusted size of US$ 221 million by 2031 with a CAGR of -7.6% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 84
USD 3950.00
(Single User License)
Global Everolimus Market Research Report 2025
The global market for Everolimus was valued at US$ 382 million in the year 2024 and is projected to reach a revised size of US$ 221 million by 2031, growing at a CAGR of -7.6% during the forecast period.
Published Date: 2025-02-25
Pages: 81
USD 2900.00
(Single User License)
Everolimus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Afinitor (everolimus) is a brand-name prescription medication. It's used to treat certain types of cancers, tumors, and seizures.
Published Date: 2024-01-24
Pages: 84
USD 3950.00
(Single User License)
Global Everolimus Market Research Report 2024
Afinitor (everolimus) is a brand-name prescription medication. It's used to treat certain types of cancers, tumors, and seizures.
Published Date: 2024-01-05
Pages: 77
USD 2900.00
(Single User License)

Everolimus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Everolimus was estimated to be worth US$ 356 million in 2025 and is projected to reach US$ 206 million, growing at a CAGR of -7.6% from 2026 to 2032.
Published: 2026-07-14
Pages: 116
USD 3950.00 (Single User License)
Global Everolimus Market Research Report 2026
The global Everolimus market was valued at US$ 356 million in 2025 and is anticipated to reach US$ 206 million by 2032, at a CAGR of -7.6% from 2026 to 2032.
Published: 2026-04-27
Pages: 123
USD 2900.00 (Single User License)
Global Everolimus Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Everolimus market is projected to grow from US$ 382 million in 2024 to US$ 221 million by 2031, at a CAGR of -7.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 110
USD 4900.00 (Single User License)
Global Everolimus Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Everolimus market size was US$ 382 million in 2024 and is forecast to a readjusted size of US$ 221 million by 2031 with a CAGR of -7.6% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 73
USD 4250.00 (Single User License)
Everolimus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Everolimus was estimated to be worth US$ 382 million in 2024 and is forecast to a readjusted size of US$ 221 million by 2031 with a CAGR of -7.6% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 84
USD 3950.00 (Single User License)
Global Everolimus Market Research Report 2025
The global market for Everolimus was valued at US$ 382 million in the year 2024 and is projected to reach a revised size of US$ 221 million by 2031, growing at a CAGR of -7.6% during the forecast period.
Published: 2025-02-25
Pages: 81
USD 2900.00 (Single User License)
Everolimus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Afinitor (everolimus) is a brand-name prescription medication. It's used to treat certain types of cancers, tumors, and seizures.
Published: 2024-01-24
Pages: 84
USD 3950.00 (Single User License)
Global Everolimus Market Research Report 2024
Afinitor (everolimus) is a brand-name prescription medication. It's used to treat certain types of cancers, tumors, and seizures.
Published: 2024-01-05
Pages: 77
USD 2900.00 (Single User License)